tradingkey.logo

SI-BONE Inc

SIBN
15.770USD
+0.580+3.82%
Fechamento 11/07, 16:00ETCotações atrasadas em 15 min
678.33MValor de mercado
PerdaP/L TTM

Mais detalhes de SI-BONE Inc Empresa

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

Informações de SI-BONE Inc

Código da empresaSIBN
Nome da EmpresaSI-BONE Inc
Data de listagemOct 17, 2018
CEOMs. Laura A. Francis
Número de funcionários349
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 17
Endereço471 El Camino Real, Suite 101
CidadeSANTA CLARA
Bolsa de valoresMoscow Interbank Currency Exchange (MICEX)
PaísUnited States of America
Código postal95050
Telefone14082070700
Sitehttps://si-bone.com/
Código da empresaSIBN
Data de listagemOct 17, 2018
CEOMs. Laura A. Francis

Executivos da empresa SI-BONE Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+5.42%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.31K
-0.25%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+44.83%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
22.00K
-13.08%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+82.75%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+284.15%
Mr. Daniel W. (Dan) Wolf
Mr. Daniel W. (Dan) Wolf
Independent Director
Independent Director
2.86K
-83.33%
Mr. Michael A. Pisetsky
Mr. Michael A. Pisetsky
Secretary, Chief Business & Legal Affairs Officer
Secretary, Chief Business & Legal Affairs Officer
--
--
Mr. Anthony J. Recupero, Ph.D.
Mr. Anthony J. Recupero, Ph.D.
President - Commercial Operations
President - Commercial Operations
--
--
Ms. Laura A. Francis
Ms. Laura A. Francis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Gregory K. (Greg) Hinckley, CPA
Mr. Gregory K. (Greg) Hinckley, CPA
Independent Director
Independent Director
168.86K
+5.42%
Mr. Jeffrey W. Dunn
Mr. Jeffrey W. Dunn
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
116.31K
-0.25%
Ms. Mika Nishimura
Ms. Mika Nishimura
Independent Director
Independent Director
28.02K
+44.83%
Mr. Anshul Maheshwari
Mr. Anshul Maheshwari
Chief Financial Officer
Chief Financial Officer
22.00K
-13.08%
Ms. Jeryl Hilleman
Ms. Jeryl Hilleman
Independent Director
Independent Director
19.16K
+82.75%
Mr. Thomas A. (Tom) West
Mr. Thomas A. (Tom) West
Independent Director
Independent Director
11.73K
+284.15%

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
46.42M
95.47%
International
2.21M
4.53%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: qui, 16 de out
Atualizado em: qui, 16 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.88%
Brown Advisory
6.75%
OrbiMed Advisors, LLC
5.98%
The Vanguard Group, Inc.
5.75%
American Century Investment Management, Inc.
5.37%
Outro
69.26%
Investidores
Investidores
Proporção
BlackRock Institutional Trust Company, N.A.
6.88%
Brown Advisory
6.75%
OrbiMed Advisors, LLC
5.98%
The Vanguard Group, Inc.
5.75%
American Century Investment Management, Inc.
5.37%
Outro
69.26%
Tipos de investidores
Investidores
Proporção
Investment Advisor
42.56%
Investment Advisor/Hedge Fund
33.03%
Hedge Fund
12.03%
Private Equity
5.98%
Individual Investor
2.98%
Research Firm
2.59%
Bank and Trust
0.30%
Pension Fund
0.19%
Family Office
0.09%
Outro
0.25%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
361
41.74M
96.76%
-3.86M
2025Q2
375
42.98M
99.64%
-3.69M
2025Q1
387
43.81M
102.83%
-3.10M
2024Q4
376
42.78M
100.80%
-4.52M
2024Q3
370
42.61M
102.18%
-5.88M
2024Q2
364
42.74M
103.69%
-5.64M
2024Q1
363
42.76M
104.26%
-3.79M
2023Q4
363
41.07M
101.66%
-4.86M
2023Q3
356
41.24M
102.85%
-4.82M
2023Q2
355
40.07M
113.82%
-3.95M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
2.97M
6.88%
-257.35K
-7.98%
Jun 30, 2025
Brown Advisory
2.91M
6.75%
-274.42K
-8.61%
Jun 30, 2025
OrbiMed Advisors, LLC
2.58M
5.98%
-863.87K
-25.09%
Jun 30, 2025
The Vanguard Group, Inc.
2.44M
5.66%
+4.38K
+0.18%
Jun 30, 2025
American Century Investment Management, Inc.
2.32M
5.37%
-325.90K
-12.33%
Jun 30, 2025
Champlain Investment Partners, LLC
2.14M
4.96%
-455.66K
-17.55%
Jun 30, 2025
First Light Asset Management, LLC
1.75M
4.06%
+138.59K
+8.60%
Jun 30, 2025
Silvercrest Asset Management Group LLC
1.48M
3.43%
-142.70K
-8.79%
Jun 30, 2025
Granahan Investment Management, LLC
1.26M
2.93%
-168.37K
-11.75%
Jun 30, 2025
State Street Investment Management (US)
1.03M
2.38%
-53.06K
-4.91%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
SPDR S&P Health Care Equipment ETF
0.79%
Hypatia Women CEO ETF
0.47%
Invesco NASDAQ Future Gen 200 ETF
0.43%
iShares Micro-Cap ETF
0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.11%
iShares U.S. Medical Devices ETF
0.07%
Principal U.S. Small-Cap ETF
0.06%
First Trust Active Factor Small Cap ETF
0.04%
iShares Russell 2000 Growth ETF
0.03%
Vanguard US Momentum Factor ETF
0.03%
Ver Mais
SPDR S&P Health Care Equipment ETF
Proporção0.79%
Hypatia Women CEO ETF
Proporção0.47%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.43%
iShares Micro-Cap ETF
Proporção0.11%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporção0.11%
iShares U.S. Medical Devices ETF
Proporção0.07%
Principal U.S. Small-Cap ETF
Proporção0.06%
First Trust Active Factor Small Cap ETF
Proporção0.04%
iShares Russell 2000 Growth ETF
Proporção0.03%
Vanguard US Momentum Factor ETF
Proporção0.03%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI